Skip to main content
Clinical Trials/CTRI/2023/02/049933
CTRI/2023/02/049933
Completed
未知

To evaluate the in-vivo safety and efficacy of the skin care formulation in terms of reduction in acne severity, reduction in sebum and Acne PIH spot on healthy female &male subjects.

HONASA CONSUMER PVT LTD. (MAMAEARTH)0 sites38 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
HONASA CONSUMER PVT LTD. (MAMAEARTH)
Enrollment
38
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 6, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
HONASA CONSUMER PVT LTD. (MAMAEARTH)

Eligibility Criteria

Inclusion Criteria

  • The study will be conducted on subjects who will fulfill the following criteria:
  • 1\.Indian male and female subjects
  • 2\.Healthy subjects (no infectious and evolutive pathology which could make the subject
  • vulnerable and stop the study, no pathology which could interfere with the study, no
  • symptom in the process of an exploratory checkup)
  • 3\.Between 18 and 30 years of age.
  • 4\.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory
  • 5\.Having mild to moderate acne.
  • 6\.Having mixed oily or oily skin on the face.
  • 7\.Having acne PIH dark spot (with at least one dark spot \>3\.5 mm in diameter).

Exclusion Criteria

  • 1\.For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past
  • three months
  • 2\.Having refused to give her/his assent by not signing the consent form
  • 3\.Taking part in another study liable to interfere with this study
  • 4\.Being insulin\-dependent diabetic or non insulin\-dependent diabetic with a recent therapy
  • (less than 6 months)
  • 5\.Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • 6\.Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
  • (except for specific studies on a determined dermatosis)
  • 7\.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6

Outcomes

Primary Outcomes

Not specified

Similar Trials